The Business Research Company’s Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030
LONDON, GREATER LONDON, UK, April 29, 2021 /EINPresswire.com/ — According to the new market research report ‘Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth And Change To 2030’ published by The Business Research Company, the checkpoint inhibitors market is expected to reach $39.81 billion in 2025 at a CAGR of 22%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the checkpoint inhibitors market during the forecast period.
Request For A Sample For The Global Checkpoint Inhibitors Market Report:
The checkpoint inhibitors market consists of sales of the immune checkpoint inhibitor drugs and related services by entities (organizations, sole traders and partnerships) that produce checkpoint inhibitors for treating cancer. A checkpoint inhibitor is a drug that blocks proteins that stop the body’s immune system from killing the cancer cells. One type of cell in the immune system that fights cancer cells are T-cells. T cells have proteins on them that turn on immune response and other proteins that turn it off. These are called checkpoints. Some checkpoints help T-cells to become active while others help T-cells to switch off. When cancer cells produce high levels of proteins, the switch off checkpoints restrict the immune responses from being strong and sometimes even stops the T-cells from killing the cancer cells. When the checkpoints are blocked by the checkpoint inhibitor from binding with its partner proteins, this allows the T-cells to kill the cancer cells.
Trends In The Global Checkpoint Inhibitors Market
Major companies in the checkpoint inhibitor market are forming partnerships or collaborations for the development of advanced technologies such as bifunctional fusion protein or Y-trap. Most patients with cancer do not respond to immune checkpoint inhibitors. To make immunotherapies more effective, a group of researchers has developed the bifunctional fusion protein or Y-trap. This drug is created by fusing a receptor for a protein called TGF-beta that targets checkpoint protein such as PD-L1 or CTLA-4. Y-Trap targets both a checkpoint inhibitor and TGF-beta and gives a more effective way to block the immune suppression and destroy the cancer cells.
Global Checkpoint Inhibitors Market Segments:
The global checkpoint inhibitors market is further segmented based on drug, application, end user and geography.
By Drug: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4, Chimeric Antigen Receptor T-Cell, Others.
By Application: Lung Cancer, Renal Cancer, Blood Cancer, Bladder Cancer, Melanoma, Others.
By End-User: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies.
By Geography: The global checkpoint inhibitors market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Checkpoint Inhibitors Market At:
Checkpoint Inhibitors Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides checkpoint inhibitors market overviews, analyzes and forecasts market size and growth for the global checkpoint inhibitors market, checkpoint inhibitors market share, checkpoint inhibitors market players, checkpoint inhibitors global market segments and geographies, checkpoint inhibitors global market’s leading competitors’ revenues, profiles and market shares. The checkpoint inhibitors market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Checkpoint Inhibitors Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Checkpoint Inhibitors Market Organizations Covered: AstraZeneca PLC, Bristol-Myers Squibb Company, Merck & Co., Inc., Roche Holding AG, Pfizer, Incyte Corporation,
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Checkpoint Inhibitors Global Market Report 2021:
Oncology Drugs Market – By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies – Global Forecast To 2030
Generic Pharmaceuticals Global Market Report 2021: COVID-19 Growth And Change To 2030
Drugs For Immunotherapy Global Market Report 2021: COVID-19 Growth And Change To 2030
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293